Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Walker

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Biotheoretica|March 1, 1992
Cancer as a mechanism of hypermutationE H Walker
Perspectives in Biology and Medicine|January 1, 1980
Chemically triggered time delay activation chemotherapy for the treatment of cancerE H Walker
RN|November 1, 1990
When the "patient" is a whole communityE H Walker, C B Neunzert
Annals of the New York Academy of Sciences|October 12, 1996
Towards engineering an improved morphine dehydrogenaseE H Walker, N C Bruce
The British Journal of Clinical Practice|August 1, 1971
Inhibition of lactation--a triple studyI Brett, C P Douglas, E H Walker
Nature|December 2, 1999
Structural insights into phosphoinositide 3-kinase catalysis and signallingE H Walker, O Perisic, C Ried, et al.
The Biochemical Journal|January 22, 2000
Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivationE H Walker, C E French, D A Rathbone, et al.
Applied and Environmental Microbiology|December 1, 2000
Cofactor regeneration by a soluble pyridine nucleotide transhydrogenase for biological production of hydromorphoneB Boonstra, D A Rathbone, C E French, et al.
Molecular Cell|November 25, 2000
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporineE H Walker, M E Pacold, O Perisic, et al.
Cell|January 4, 2001
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gammaM E Pacold, S Suire, O Perisic, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Biotheoretica|March 1, 1992
Cancer as a mechanism of hypermutationE H Walker
Perspectives in Biology and Medicine|January 1, 1980
Chemically triggered time delay activation chemotherapy for the treatment of cancerE H Walker
RN|November 1, 1990
When the "patient" is a whole communityE H Walker, C B Neunzert
Annals of the New York Academy of Sciences|October 12, 1996
Towards engineering an improved morphine dehydrogenaseE H Walker, N C Bruce
The British Journal of Clinical Practice|August 1, 1971
Inhibition of lactation--a triple studyI Brett, C P Douglas, E H Walker
Nature|December 2, 1999
Structural insights into phosphoinositide 3-kinase catalysis and signallingE H Walker, O Perisic, C Ried, et al.
The Biochemical Journal|January 22, 2000
Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivationE H Walker, C E French, D A Rathbone, et al.
Applied and Environmental Microbiology|December 1, 2000
Cofactor regeneration by a soluble pyridine nucleotide transhydrogenase for biological production of hydromorphoneB Boonstra, D A Rathbone, C E French, et al.
Molecular Cell|November 25, 2000
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporineE H Walker, M E Pacold, O Perisic, et al.
Cell|January 4, 2001
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gammaM E Pacold, S Suire, O Perisic, et al.
Pageof 1